The usefulness of Biohit GastroPanel[®] biomarkers in diagnosis of atrophic gastritis confirmed in a multi-center study in France
Biohit Oyj press release 6.8.2020 at 10.05 local time (EEST) GastroPanel[®] biomarker test is a unique innovation of a Finnish biotechnology company (Biohit Oyj, Helsinki), designed for the first-line diagnosis of all patients with upper abdominal symptoms (dyspepsia) and reflux complaints (1,2). This first non-invasive diagnostic test on the market accurately confirms or excludes the presence of Helicobacter pylori (Hp) infection and atrophic gastritis (AG) (1,2). At the same time, GastroPanel[®] is the only test monitoring the acid output regulatory mechanism in the stomach. Hp